[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338149-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338149-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","modelling-incidence-and-mortality-cancer-parameters-with-respect-to-globocan-2020-research-article","Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020 - Research article","","An empirical model is developed for female cancer incidences and deaths using life expectancy data from GLOBOCAN world estimates. The approach applies cumulative risk and exponential correlation to evaluate adjustable parameters and characterize gender-specific trends. Results indicate a rapid rise in female cancer morbidity as male case counts increase, and a convergence toward a virtual limiting value at extremely high male levels. Separate region-by-sex modelling reveals inflection behavior for incidences and non-linear dependence for mortality, with male increases more pronounced than female increases. The study supports targeted prevention and resource planning across regions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/modelling-incidence-and-mortality-cancer-parameters-with-respect-to-globocan-2020-research-article/338149/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/modelling-incidence-and-mortality-cancer-parameters-with-respect-to-globocan-2020-research-article/338149.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data source is used to build the model?","Question",{"text":63,"@type":64},"The model uses life expectancy data from GLOBOCAN world estimates for different cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the model treat female cancer incidences and deaths?",{"text":68,"@type":64},"Female cancer incidences and deaths are modelled using adjustable parameters, supported by cumulative risk and exponential correlation techniques.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the findings suggest about gender-specific patterns?",{"text":72,"@type":64},"Female cancer morbidity increases rapidly with male cancer case numbers and shows inflection-related behavior by region, while mortality shows non-linear dependence with a stronger increase for males than for females.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338149,1790434230,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Heliyon 10 (2024) e36836  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020Age standardized world estimates\u003Cbr>Joseph Acquaha , Senyefia Bosson-Amedenub, Francis Eyiah-Bediako c , Albert Buabenga, * , Noureddine Ouerfellid\u003Cbr>a Mathematical Sciences Department, University of Mines and Technology, Tarkwa, Ghana\u003Cbr>b Department of Mathematics, Statistics and Actuarial Science, Takoradi Technical University, Takoradi, Ghana c Department of Statistics, University of Cape Coast, Cape Coast, Ghana\u003Cbr>d Institut Sup´erieur des Technologies M´edicales de Tunis, LR13SE07, Laboratoire de Biophysique et Technologies M´edicales, Universit´e de Tunis El Manar, Tunis, Tunisia |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Cancer\u003Cbr>GLOBOCAN Cumulative incidence Mortality Age Standardised |  | In this paper, an empirical model with the critical number of incidences and deaths for female cancers as adjustable parameters has been developed using life expectancy data from GLOBOCAN world estimates on cancer types. The model was developed based on the cumulative risk and exponential correlation techniques such that the significance of the adjustable parameters ascertains the strength of this research in two ways. First, it indicates indicates the rapid increase in female cancer morbidity with increase in the number of male cancer cases, regardless of incidence or mortality. Second, it suggests that female cancer cases may approach a virtual limiting value as male cancer cases reach extremely high levels. This projection aligns with the global population trends, indicating a proportional increase in cancer cases each year. Additionally, the cumulative risk of cancer incidences of each sex has been modelled separately against the global cumulative risk of cancer incidences of both sexes which revealed regions that have passed their inflection point and those that are yet to reach the inflection point. There was a curvature change, which indicates an inflection point coinciding with the South-Eastern Region and indicating that for the regions beyond the inflection point, the increase of the cumulative risk of cancer incidences of females against that of males is more accentuated compared with the regions before the inflection point. However, when the cumulative risk of cancer mortality of each sex is modelled separately against the global cumulative risk of cancer mortality of both sexes shows a non-linear dependence and the increase is more accentuated for males than for females. This finding indicates that cumulative risk is influenced by factors beyond the male-female population ratio. This study advances cancer studies as it provides a nuanced understanding of gender-specific cancer trends, crucial for developing targeted cancer prevention and treatment strategies. By elucidating the dynamics of cancer incidences and mortalities across different regions and sexes, the findings can inform public health policies and resource allocation to combat cancer more effectively on a global scale. |\n\n* Corresponding author. Mathematical Sciences Department, University of Mines and Technology, Tarkwa, Ghana.  \nE-mail address: [abuabeng@umat.edu.gh](abuabeng@umat.edu.gh) (A. Buabeng).  \n[https://doi.org/10.1016/j.heliyon.2024.e36836](https://doi.org/10.1016/j.heliyon.2024.e36836)  \nReceived 6 June 2023; Received in revised form 31 July 2024; Accepted 22 August 2024  \n2405-8440/© 2024 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license  \n([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n1. Introduction  \nA strong foundation for estimating the global cancer burden was lacking until recently due to insufficient da","cbCaioeYXKVqSUpt","https://ap.wps.com/l/cbCaioeYXKVqSUpt","pdf",837678,15,"English","# Introduction\n## Global context of cancer burden\n## Regional and gender differences in incidence and mortality","[{\"question\":\"What data source is used to build the model?\",\"answer\":\"The model uses life expectancy data from GLOBOCAN world estimates for different cancer types.\"},{\"question\":\"How does the model treat female cancer incidences and deaths?\",\"answer\":\"Female cancer incidences and deaths are modelled using adjustable parameters, supported by cumulative risk and exponential correlation techniques.\"},{\"question\":\"What do the findings suggest about gender-specific patterns?\",\"answer\":\"Female cancer morbidity increases rapidly with male cancer case numbers and shows inflection-related behavior by region, while mortality shows non-linear dependence with a stronger increase for males than for females.\"}]","Modelling incidence and mortality cancer parameters with respect to GLOBOCAN 2020 - Research article | PDF",1790022224,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48d3e205bde276500ecd1e708d4b963f.webp",983,1341,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4e26ada92057a4c8ae7da496169eb7e.webp",982,1340,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0478fad1cf4e705f434d7a20e52985f3.webp",981,1338,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3da4e8ac180802bcb44e97eba8409055.webp",980,1337]